4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations-Reference-Cited by-同舟云学术

4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations

Published:2009-05 Issue:10 Volume:19 Page:2683-2687
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Parmenon Cécile,Guillard Jérôme,Caignard Daniel-Henri,Hennuyer Nathalie,Staels Bart,Audinot-Bouchez Valérie,Boutin Jean-Albert,Dacquet Catherine,Ktorza Alain,Viaud-Massuard Marie-Claude

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference21 articles.

1. The RXR heterodimers and orphan receptors

2. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

3. The Mechanisms of Action of PPARs

4. Therapeutic Roles of Peroxisome Proliferator–Activated Receptor Agonists

5. PPARs: therapeutic targets for metabolic disease

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing of target‐specific N‐substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure‐guided computational approaches;ChemistrySelect;2024-02-14

2. Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer;Future Medicinal Chemistry;2022-12

3. The Role of the Hypothalamus–Pituitary–Adrenal (HPA) Axis in Test-Induced Anxiety: Assessments, Physiological Responses, and Molecular Details;Stresses;2022-03-14

4. Advances in the reduction of quinolines to 1,2,3,4‐tetrahydroquinolines;Journal of Heterocyclic Chemistry;2021-12-19

5. Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists;Journal of Enzyme Inhibition and Medicinal Chemistry;2020-01-01